Log in

CNSX:ISOL - Isodiol International Stock Price, Forecast & News

Today's Range N/A
50-Day Range
MA: $0.62
52-Week Range N/A
Volume1.39 million shs
Average Volume164,946 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Isodiol International Inc engages in the development, marketing, distribution, and sale of hemp-based consumer products and solutions in Canada, Latin America, Asia, and Europe. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products. Read More…

Industry, Sector and Symbol

Industry Software - Application
SectorComputer and Technology



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive ISOL News and Ratings via Email

Sign-up to receive the latest news and ratings for ISOL and its competitors with MarketBeat's FREE daily newsletter.

Isodiol International (CNSX:ISOL) Frequently Asked Questions

What is Isodiol International's stock symbol?

Isodiol International trades on the CNSX under the ticker symbol "ISOL."

Has Isodiol International been receiving favorable news coverage?

Media headlines about ISOL stock have trended somewhat positive recently, InfoTrie reports. The research group identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Isodiol International earned a news impact score of 1.5 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Isodiol International.

Who are some of Isodiol International's key competitors?

What other stocks do shareholders of Isodiol International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Isodiol International investors own include Eguana Technologies (EGT), Radient Technologies (RTI), Nemaska Lithium (NMX), Momo (MOMO), Isodiol International (ISOLF), Aurora Cannabis (ACB), Horizon Therapeutics (HZNP), Canopy Growth (WEED), Lifestyle Delivery Systems (LDS) and Cronos Group (CRON).

Who are Isodiol International's key executives?

Isodiol International's management team includes the folowing people:
  • Mr. Marcos Agramont, CEO, Pres & Director
  • Mr. Soheil Samimi, Advisor
  • Mr. Eli Dusenbury, Chief Financial Officer
  • Mr. Patrick Edward Ogle J.D., L.L.M., COO & Director
  • Mr. Marvin Washington, VP of Bus. Devel. & Director

How do I buy shares of Isodiol International?

Shares of ISOL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Isodiol International's official website?

The official website for Isodiol International is http://www.1mage.com/.

How can I contact Isodiol International?

The company can be reached via phone at 800-844-1468.

MarketBeat Community Rating for Isodiol International (CNSX ISOL)

Community Ranking:  3.5 out of 5 (star star star half star)
Outperform Votes:  81 (Vote Outperform)
Underperform Votes:  35 (Vote Underperform)
Total Votes:  116
MarketBeat's community ratings are surveys of what our community members think about Isodiol International and other stocks. Vote "Outperform" if you believe ISOL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ISOL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel